| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 11/09/2004 | US6815553 Birch bark processing and the isolation of natural products from birch bark |
| 11/04/2004 | WO2004074216A3 Carnitine salt, preliposome which contains it and dermo-cosmetic formula for topical use based upon said carnitine salt |
| 11/04/2004 | US20040220147 Antiarrhythmia agents; liver disorders; skin disorders |
| 11/04/2004 | DE4435647B4 Natriumsalz der Menthyloxycarbonyl-l-hydroxyl-l-methylsulfonsäure, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung von L(-)-Menthylglyoxylat Sodium salt of menthyloxycarbonyl-l-hydroxyl-l-methylsulfonic acid, process for its preparation and its use for the preparation of L (-) - menthyl glyoxylate |
| 11/03/2004 | EP1473298A1 Supermolecular carboplatinum derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions |
| 11/03/2004 | EP1472209A2 Lipoxin a4 analogs |
| 11/03/2004 | EP1144382B1 Process for preparing 1,5-diaryl-3-substituted pyrazoles |
| 11/03/2004 | CN1543462A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 11/03/2004 | CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar) |
| 11/03/2004 | CN1173914C Improved separation processes |
| 11/02/2004 | US6812363 Racemization of optically active 2-substituted phenyl glycine esters |
| 11/02/2004 | US6812244 Naphthyl compounds, intermediates, compositions, and methods of use |
| 10/28/2004 | WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/28/2004 | WO2004091604A1 Compounds that modulate ppar activity and methods of preparation |
| 10/28/2004 | WO2004091278A2 Gabapentin compositions |
| 10/28/2004 | WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/28/2004 | US20040214893 tartaric acid, ethanedisulfonic acid, or maleic acid salts of gabapentin; improved aqueous solubility, and dose response properties; for treating brain disorders |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 10/28/2004 | US20040213442 Novel fatty acids analogous |
| 10/28/2004 | CA2522118A1 Compounds that modulate ppar activity and methods of preparation |
| 10/28/2004 | CA2521915A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1196604B1 11-arachidonate-lipoxygenase mutants |
| 10/26/2004 | US6809223 Process for stereoselective synthesis of prostacyclin derivatives |
| 10/21/2004 | WO2004089890A2 Process and intermediates for preparing benzazepines |
| 10/21/2004 | WO2004089885A1 Novel compounds |
| 10/21/2004 | WO2004089884A1 Novel compounds |
| 10/21/2004 | US20040210088 Lactic acid processing; methods; arrangements; and, products |
| 10/21/2004 | US20040210087 Process for preparing carboxylic acids and derivatives thereof |
| 10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
| 10/21/2004 | US20040209847 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/20/2004 | EP1467695A2 Hiv integrase inhibitors |
| 10/20/2004 | CN1538876A Novel catalytic formulation and its preparation method |
| 10/20/2004 | CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 10/20/2004 | CN1171845C Ethylene glycol antimony acetate and its preparation method |
| 10/20/2004 | CN1171844C Lactic acid processing methods, arrangements and products |
| 10/14/2004 | WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 10/14/2004 | WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives |
| 10/14/2004 | US20040204618 Method for producing a fluorine-containing compound |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/12/2004 | US6803385 Vision defects |
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
| 10/07/2004 | WO2004060987A3 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 10/07/2004 | US20040199007 Raney copper |
| 10/07/2004 | US20040198825 Antidiabetic agents; side effect reduction |
| 10/07/2004 | US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs |
| 10/07/2004 | US20040197882 for producing 13-hydroxy-9-octadecenoic acid using pediococcus pentosaceus or bifidobacterium bifidum |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1208075B1 Process for producing a vic-dichloro acid fluoride |
| 10/06/2004 | CN1534010A Water soluble extract of red sage root and its preeparation method and use |
| 10/06/2004 | CN1169781C Prcess for prepn. of salts of L-carnitine and alkanoyl L-carnitine with mucic acid |
| 09/30/2004 | WO2004069781A3 7-(3,5-diisopropylphenyl) heptatrienoic acid derivatives having serum glucose reducing activity |
| 09/30/2004 | US20040192962 Treating cyclohexylphenyl ketone with ylide in anhydrous solvent to obtain a-cyclohexylstyrene; dihydroxylation, oxidation |
| 09/30/2004 | US20040192960 Process for the optical resolution of a precursor of sclareolide |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | CN1533372A Process and intermediates to prepare latanoprost |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080940A1 Process for production of perfluorodiacyl fluorides |
| 09/23/2004 | US20040186165 action similar to Taxol but it is active against Taxol-resistant cell lines and it is more water soluble; anticarcinogenic |
| 09/23/2004 | US20040186162 preparation of the amorphous inhibitor and its hydrates of desired particle size which comprises dissolving the inhibitor in a hydroxylic solvent (methanol), then removing the solvent by freeze-drying |
| 09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
| 09/23/2004 | CA2516342A1 Process for producing perfluorodiacyl fluorinated compounds |
| 09/22/2004 | EP1458372A1 Calcium l-threonate for preventing or treating cartilage related diseases |
| 09/22/2004 | EP1163200B1 Method of industrial-scale purification of lactic acid |
| 09/22/2004 | CN1167662C Process for producing vic-dichloro acid fluoride |
| 09/21/2004 | US6794540 Process for the preparation of sorbic acid |
| 09/21/2004 | CA2347758C Method for racemate splitting of 2-hydroxypropionic acids |
| 09/21/2004 | CA2121020C Process to prepare amino carboxylic acid salts |
| 09/16/2004 | WO2004069782A3 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 09/16/2004 | WO2003105776A3 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics |
| 09/16/2004 | DE10217208B4 Verwendung von Ethercarbonsäuren mit niedrigem Stockpunkt Use of ether carboxylic acids with low pour point |
| 09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
| 09/15/2004 | EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them |
| 09/15/2004 | EP1094999B1 Production of organic compounds which are low in fluoride |
| 09/15/2004 | EP0702517B1 Quaternary ammonium and waterproofing/preservative compositions |
| 09/15/2004 | CN1528729A Process for preparing ether carboxylate |
| 09/15/2004 | CN1166616C Process and apparatus for purifying raw lactic acid |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790953 Ether compounds |
| 09/10/2004 | WO2004056832A3 Epothilone derivatives |
| 09/10/2004 | WO2004054957A3 Valproic acid analogues and pharmaceutical compositions thereof |
| 09/09/2004 | US20040176645 Process for stereoselective synthesis of prostacyclin derivatives |
| 09/09/2004 | US20040176432 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP0910331B1 Oxa diacids and related compounds for treating skin conditions |
| 09/07/2004 | CA2166898C Novel structural analogues of vitamin d |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/07/2004 | CA2100031C Smoking compositions containing an alpha-alkylcinnamaldehyde-release additive |